Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical combinations of a CDK4/6 inhibitor and a B-RAF inhibitor

Pharmaceutical combinations of a CDK4/6 inhibitor and a B-RAF inhibitor

US Patent 9700557 · Granted Jul 11, 2017

Estimated economic value: $14,937,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic combinations comprising a c-RAF inhibitor2024
Therapeutic combinations comprising a c-RAF inhibitor2024
High activity platinum and nickel yolk-shell catalysts2023
Direct synthesis of light olefins from carbon dioxide using yttria-stabilized zi2023
Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers2022
Pharmaceutical combinations2022
Method of treating a proliferative disease2021
Therapeutic uses of a C-RAF inhibitor2021
Therapeutic uses of a C-RAF inhibitor2021
Combination therapy2020
Combination therapy2020
Pharmaceutical combinations2019